Akt1-and-Akt2-IN-1 - Akt 抑制剂 - 生命科学试剂 - MedChemExpress_第1页
Akt1-and-Akt2-IN-1 - Akt 抑制剂 - 生命科学试剂 - MedChemExpress_第2页
Akt1-and-Akt2-IN-1 - Akt 抑制剂 - 生命科学试剂 - MedChemExpress_第3页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEAkt1 and Akt2-IN-1Cat. No.: HY-50862CAS No.: 893422-47-4分式: CHNO分量: 539.63作靶点: Akt作通路: PI3K/Akt/mTOR储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 35 mg/mL (64.86 mM)* means soluble, but s

2、aturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 1.8531 mL 9.2656 mL 18.5312 mL5 mM 0.3706 mL 1.8531 mL 3.7062 mL10 mM 0.1853 mL 0.9266 mL 1.8531 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Akt1 and Akt2-IN-1种有效的变构抑制剂, 抑制 Akt1 (IC50=3.5 nM) 和 Akt2 (IC50=4

3、2 nM)。IC50 & Target Akt1 Akt23.5 nM (IC50) 42 nM (IC50)体外研究Consistent with the allosteric mode of inhibition, Akt1 and Akt2-IN-1 (Compound 17) is dependent on the PH-1/2 Master of Small Molecules 您边的抑制剂师www.MedChemEdomain for Akt inhibition, is selective for Akt1/2 over Akt3 (IC50=1900 nM), and is h

4、ighly selective over othermembers of the AGC family of kinases (50 M vs PKA, PKC, SGK). Akt1 and Akt2-IN-1 (Compound 17) hasmoderate activity in an hERG binding assay (IC50=5610 nM) and is a substrate for human P-glycoprotein 1.体内研究 Akt1 and Akt2-IN-1 (Compound 17) is well tolerated in at exposures

5、that provide high levels of Akt1 and 2inhibition in vivo. Akt1 and Akt2-IN-1 (Compound 17) has also been shown to inhibit the growth of A2780tumors in vivo when used as monotherapy. Akt1 and Akt2-IN-1 (Compound 17) has potent inhibitory activityagainst Akt1 and 2 in vivo in a mouse lung and efficacy

6、 in a tumor xenograft model. Akt1 and Akt2-IN-1(Compound 17) shows good pharmacokinetics in rat with a low clearance of 4.6 mL/min/kg and a half-life of3.8 h. Due to the improved cell potency, physical properties, and rodent pharmacokinetics of Akt1 and Akt2-IN-1 (Compound 17), tolerability and Akt

7、inhibition are assessed in mice. Using an acute dosing schedule (IPdosing of 50 mg/kg at times 0, 3, and 8 h), administration of Akt1 and Akt2-IN-1 (Compound 17) is welltolerated in mice and shows high levels of Akt inhibition in mouse lung 1.REFERENCES1. Bilodeau MT, Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model. Bioorg MedChem Lett. 2008 Jun 1;18(11):3178-82.McePdfHeightCaution: Product has not been fully validated for medical applications.For rese

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论